Sleep Patterns Changes Depending on Headache Subtype and Covariates of Primary Headache Disorders

Headache is one of the most common and bothersome problems in neurology practice. The frequency of headache has been substantially increased over the last 30 years due to changes in lifestyle. Controlling the trigger factors and lifestyle changes (e.g. regular sleep, meal time, exercise, etc.) are the first step management strategies in headaches. Sleep and headache have bidirectional effects on each other. While diminished and poor quality of sleep can be a trigger factor for headache (e.g. migraine and tension-type headache (TTH)), some types of headache like hypnic headache and cluster-type headache mainly occur during sleep. Patients with headache may have poor sleep quality, reduced total sleep time, more awakenings, and alterations in architecture of sleep recorded by polysomnography. Progression to chronic forms of headache may also be associated with the duration and quality of sleep. Even though pathophysiology of headache and sleep disorders shares the same brain structures and pathways, sleep disturbances are commonly underestimated and underdiagnosed in headache patients. Clinicians should consider and behold the treatment of accompanying sleep complaints for an effective management of headache

The effect of serum uric acid in patients with intracranial haemorrhage

12th Congress of the European-Federation-of-Neurological-Societies -- AUG 23-26, 2008 -- Madrid, SPAINKocer, Abdulkadir/0000-0003-2866-555XWOS: 000258379000866…European Federat Neurol So

Optic neuropathy related to hydrogen peroxide inhalation

Kocer, Abdulkadir/0000-0003-2866-555XWOS: 000244167900009PubMed: 17272972Optic neuropathy related to toxins is a complex, multifactorial disease potentially affecting individuals of all ages. We report a case of presumed toxic optic neuropathy secondary to H2O2 exposure. This has not been previously reported, and the temporal relationship of the exposure to the optic neuropathy is compelling, although not definite, evidence of a causal relationship

Optic neuropathy related to hydrogen peroxide inhalation

Kocer, Abdulkadir/0000-0003-2866-555XWOS: 000244167900009PubMed: 17272972Optic neuropathy related to toxins is a complex, multifactorial disease potentially affecting individuals of all ages. We report a case of presumed toxic optic neuropathy secondary to H2O2 exposure. This has not been previously reported, and the temporal relationship of the exposure to the optic neuropathy is compelling, although not definite, evidence of a causal relationship

A Reason for Admission to the Sleep Outpatient Clinic during COVID-19 Pandemic: Insomnia

Aim: Sleep can be affected for various reasons such as social isolation, online education, shiftwork, etc. during the coronavirus disease 2019 (COVID-19) pandemic. People who havecomorbid psychiatric or sleep disorders before the pandemic are thought to be more affected.The aim of this study was to investigate the effect of the COVID-19 pandemic on sleep qualityand insomnia.Material and Methods: Our study was a retrospective study, and patients who admitted to thesleep outpatient clinic with insomnia complaints during the COVID-19 pandemic wereincluded. The complaints, sociodemographic characteristics, and diagnosis of the patients wereobtained from medical records.Results: Fifty-three patients diagnosed with insomnia according to the InternationalClassification of Sleep Disorders third edition (ICSD-3) were included in the study. The meansleep time before the pandemic was 6.8±1.2 hours, while it was 5.9±1.7 hours after thepandemic. After the pandemic, 13 (24.5%) patients had shortened sleep duration. There wasno difference in clinical features between those whose sleep duration decreased and did notchange during the pandemic. Twenty (37.7%) patients' complaints of insomnia started duringthe pandemic. Most of the patients whose complaints started during the pandemic were male(n=12, 60.0%). Their main complaint was difficulty in falling asleep (n=18, 90.0%). Theanxiety symptoms were remarkable.Conclusion: Sleep disorders during the pandemic are an important problem for everyone.However, some individuals have a higher risk of sleep problems. Therefore, the results of ourstudy may contribute to the interventions aimed at improving sleep quality during pandemic

A Reason for Admission to the Sleep Outpatient Clinic during COVID-19 Pandemic: Insomnia

Aim: Sleep can be affected for various reasons such as social isolation, online education, shiftwork, etc. during the coronavirus disease 2019 (COVID-19) pandemic. People who havecomorbid psychiatric or sleep disorders before the pandemic are thought to be more affected.The aim of this study was to investigate the effect of the COVID-19 pandemic on sleep qualityand insomnia.Material and Methods: Our study was a retrospective study, and patients who admitted to thesleep outpatient clinic with insomnia complaints during the COVID-19 pandemic wereincluded. The complaints, sociodemographic characteristics, and diagnosis of the patients wereobtained from medical records.Results: Fifty-three patients diagnosed with insomnia according to the InternationalClassification of Sleep Disorders third edition (ICSD-3) were included in the study. The meansleep time before the pandemic was 6.8±1.2 hours, while it was 5.9±1.7 hours after thepandemic. After the pandemic, 13 (24.5%) patients had shortened sleep duration. There wasno difference in clinical features between those whose sleep duration decreased and did notchange during the pandemic. Twenty (37.7%) patients' complaints of insomnia started duringthe pandemic. Most of the patients whose complaints started during the pandemic were male(n=12, 60.0%). Their main complaint was difficulty in falling asleep (n=18, 90.0%). Theanxiety symptoms were remarkable.Conclusion: Sleep disorders during the pandemic are an important problem for everyone.However, some individuals have a higher risk of sleep problems. Therefore, the results of ourstudy may contribute to the interventions aimed at improving sleep quality during pandemic

Clinic, Etiology and Prognosis in Cerebral Venous Thrombosis

OBJECTIVE: Scientific BACKGROUND: Cerebral venous thrombosis is seen rarely according to arterial stroke and effects every age group. Onset and process is variable and usually a good prognosis occurs. Early development of coma and intracranial hemorrhage are bad prognostic factors. In our study, it is aimed to investigate the neurologic deficits, etiological factors, localization and the prognosis of the patients who are hospitalized with the diagnosis of cerebral venous thrombosis in our in-patient clinic. METHODS: METHOD: Patients were investigated with routine hematologic, biochemical and vasculitic tests and cranial MRI and MR venography RESULTS: RESULTS: Of fifteen patients, 10 were women and 5 were men. Mean age was 47.2 and age interval was 17-80. 5 patients in acute, 6 patients in subacute and 4 patients in chronic stage had admitted to our clinic. Mostly seen complaint was headache (11 patients) and 7 patients had paresis, 6 had epileptic seizures, 6 had visual deficits and 1 had unsteadiness. 9 patients had superior sagittal, 2 had superior sagittal+trasverse, 2 had superior sagittal+rectus+transverse, 1 had rectus+transverse and 1 had transverse sinus thrombosis. 2 patients had subarachnoid hemorrhage, 2 had lobar hematoma, 1 had subdural hematoma and 1 had hemorrhagic infarct. Etiologically 3 cases were in postpartum period and 1 case was pregnant. 1 patient had protein C deficiency, 1 had activated protein C resistancy, 1 had antithrombin III deficiency, 1 had anticardiolipin antibody positivity and 1 had thrombocytosis. There was no etiological resason in 4 of the cases and 1 patient could not be investigated because of the death of the patient in the early period. 9 patients recovered completely, 3 patients recovered partially and 2 patients had permanent visual loss. CONCLUSION: CONCLUSION: Cerebral venous thrombosis needs highly suspection in order to define the clinical signs. As the early treatment prevents exitus and severe disability, early diagnosis is very importan

Heerfordt Syndrome: A Case Report

Heerfordt syndrome is a form of neurosarcoidosis with the combination of fever, enlargement of the parotid gland, anterior uveitis, and facial nerve paralysis. We present a 38-year-old female patient who had a solid and painful swelling behind each ear 20 days after the complaints of redness of both eyes, fatigue, night sweat, and weight loss. Three weeks later, right facial paralysis developed, and the patient was seen in our outpatient clinic. On physical examination, bilateral solid and painful masses were observed on the parotid glands. Neurological examination was normal except for the right facial nerve paralysis. Ophthalmologic examination revealed bilateral anterior uveitis. Cranial magnetic resonance imaging was normal. On parotid gland magnetic resonance imaging, enlargement, lobulation and cystic lesions on both parotid glands with heterogeneous contrast involvement were observed. Parotid biopsy showed non-necrotizing granulomatous sialadenitis. There were multiple nodules on both lungs on mediastinum computerized tomography. Laboratory tests revealed: C-reactive protein 0.75 mg/dL, erythrocyte sedimentation rate 26 mm/hour and angiotensin-converting enzyme 83 U/L (N: 8-52 U/L) Though the patient, diagnosed as Heerfordt syndrome, had phase 1 sarcoidosis, she was treated with 45 mg/day steroid because of the multiple organ involvement. In conclusion, Heerfordt syndrome, a rare manifestation of neurosarcoidosis, must be kept in mind in the differential diagnosis of facial nerve paralysis

A comparison of sural nerve conduction studies in patients with impaired oral glucose tolerance test

KOCER, ABDULKADIR/0000-0003-2866-555XWOS: 000250617900009PubMed: 17986099Objective - Monitoring of the sural nerve is a sensitive method for detection of neuropathies. We examined different methods of studying sural nerve conduction in a group of patients with impaired glucose tolerance (IGT) in the same study. Materials and methods - Several parameters of sural nerve were investigated in 20 patients. First, sensory nerve conduction studies of the sural nerve were performed on the distal-leg and the proximal-leg segments. Second, dorsal sural nerve studies were conducted. Third, the sural/radial sensory nerve action potential (SNAP) amplitude ratios were calculated. The results were compared with those obtained from 21 healthy controls. Results - Abnormal results revealing peripheral neuropathy were found in only one patient and dorsal sural SNAP was absent in another patient (5%). Although the results of nerve conduction studies were within normal ranges except the patient with peripheral neuropathy, the lower extremity nerves and especially sural nerves have been found to be more affected and the parameters revealed large differences between groups (P < 0.05). Only dorsal sural nerve latency related to fasting blood glucose level in patients (< 0.05). Conclusions - Sural nerve studies should be of value to determine neuropathy in IGT patients. This study supported the idea that IGT is a transitional state before diabetes and also the importance of the dorsal sural nerve latencies for early detection of neuropathy